產(chǎn)品展示
公司專業(yè)銷售生化試劑,氨基酸類,酶類,蛋白質(zhì)類,植物激素及核酸類,碳水化合物類,色素類,緩沖劑類,培養(yǎng)基類,涉及到分析科學(xué),生命科學(xué),化學(xué),材料科學(xué)。了解更多產(chǎn)品!
藍(lán)色瓊脂糖凝膠6FF藍(lán)色瓊脂糖凝膠6FF/Blue Sepharose 6FF BR 25毫升 pharmacia 7-0948-022~8℃
25毫升 ,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌,
產(chǎn)品名稱 | |
英文名稱 | Blue Sepharose 6FF |
規(guī)格 | 可接受大包訂制 |
中文名稱:
英文名稱: Blue Sepharose 6FF
產(chǎn)品規(guī)格: 進(jìn)分
包裝:25毫升
產(chǎn)品規(guī)格: 國產(chǎn)
包裝:25毫升
級別:BR
Total binding capacity:>8mg human serum albumin/ml drained medium
Ligand density:approx 7umol cibacron Blue 3G/ml drained medium
Bead structure:highly cross-linked 6% agarose
Average particle size:90um(45-65um)
pH stability:long term 4-2 and short term 3-3
Linear flow velocity:300cm/h(at 25℃,XK 50/30 column,5 cm bed height)
Chemical stability:7 days at 40℃ in : 70% ethanol;6 M guanidine-hydrochloride,8 M urea
基質(zhì):6%交聯(lián)瓊脂糖凝膠
配基:藍(lán)色染料
配基密度:~0μmol/ml
粒度:45~65um
吸附載量:20mg BSA/ml
zui大流速:300cm/h
耐壓:0.3mPa
pH范圍:3-0,在位清洗時pH范圍可到2-3
性狀:藍(lán)色液體,底部為膠體
用途:生化研究。純化各種需要NAD、NADP作為輔酶的的酶類、白蛋白、、干擾素等
保存:2~8℃
是我司的優(yōu)勢產(chǎn)品,在行業(yè)中獲得許多客戶的贊譽(yù)。平易的價格,讓您補(bǔ)足實驗“糧響”。我司專業(yè)供應(yīng)科研實驗試劑,保質(zhì)保量。嚴(yán)格操作,技術(shù)成熟。科研博大精深,學(xué)科之間相互滲透,我們以滿足客戶需求為己任,力求全面服務(wù)于新老客戶。
細(xì)胞膜熒光探針DiD標(biāo)記溶液 DiD labeling solution [,-Dioctadecyl-3,3,3,3-tetramethylindodicarbocyanine] *5 mM DMSO solution*
細(xì)胞膜熒光探針DiA DiA [4-(4-(Dihexadecylamino)styryl)-N-methylpyridinium iodide]
活細(xì)胞熒光示蹤探針VFSE 550 VFSE 550
活細(xì)胞熒光示蹤探針VFSE 500 VFSE 500
活細(xì)胞熒光示蹤探針VFSE 450 VFSE 450
活細(xì)胞熒光示蹤探針CFSE(CFDA-SE) CFSE [5-(and 6)-Carboxyfluorescein diacetate, succinimidyl ester] *Mixed isomers*
活細(xì)胞熒光示蹤探針CFDA CFDA [5-(and 6)-Carboxyfluorescein diacetate] *Mixed isomers*
活細(xì)胞熒光示蹤探針FDA[熒光素二乙酸] FDA [Fluorescein diacetate]
熒光素二辛酸鹽 Fluorescein dicaprylate [Fluorescein dioctanoate]
CytoCalcein 紫羅蘭500 *450nm處激發(fā)* CytoCalcein Violet 500 *Excited at 405 nm*
CytoCalcein 紫羅蘭450 *450nm處激發(fā)* CytoCalcein Violet 450 *Excited at 405 nm*
鈣黃綠素紅 Calcein Red
熒光素 *熒光參照標(biāo)準(zhǔn)* Fluorescein *Fluorescence reference standard*
熒光黃二鈉鹽 *熒光參照標(biāo)準(zhǔn)* Fluorescein, disodium salt *Fluorescence reference standard*
3-氰基-7-羥基香豆素 *熒光參照標(biāo)準(zhǔn)* 3-Cyano-7-hydroxycoumarin *Fluorescence reference standard*
7-羥基-4-甲基香豆素 *熒光參照標(biāo)準(zhǔn)* 7-Hydroxy-4-methylcoumarin *Fluorescence reference standard*
CF-MU CF-MU [6-Chloro-8-fluoro-7-hydroxy-4-methylcoumarin] *Fluorescence reference standard*
AMC[7-氨基-4-甲基香豆素] *熒光參照標(biāo)準(zhǔn)* AMC [7-Amino-4-methylcoumarin] *Fluorescence reference standard*
AMC[7-氨基-4-甲基香豆素] *可標(biāo)記多肽* AMC [7-Amino-4-methylcoumarin] *Validated for labeling peptides*CID-20756 (0 mg) 5-(3-chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furancarboxamide
CID-20756 (25 mg) 5-(3-chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furancarboxamide
CID-20756 (5 mg) 5-(3-chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furancarboxamide
DBeQ (0 mg) JRF 2|N,N’-Dibenzylquinazoline-2,4-diamine; N2,N4-bis(phenylmethyl)-2,4-quinazolinediamine
DBeQ (25 mg) JRF 2|N,N’-Dibenzylquinazoline-2,4-diamine; N2,N4-bis(phenylmethyl)-2,4-quinazolinediamine
DBeQ (5 mg) JRF 2|N,N’-Dibenzylquinazoline-2,4-diamine; N2,N4-bis(phenylmethyl)-2,4-quinazolinediamine
DBeQ (50 mg) JRF 2|N,N’-Dibenzylquinazoline-2,4-diamine; N2,N4-bis(phenylmethyl)-2,4-quinazolinediamine
Ginsenoside Rb (0 mg) Gypenoside III|NSC 3003; 20-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-2β-hydroxydammar-24-en-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
Ginsenoside Rb (25 mg) Gypenoside III|NSC 3003; 20-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-2β-hydroxydammar-24-en-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
Ginsenoside Rb (5 mg) Gypenoside III|NSC 3003; 20-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-2β-hydroxydammar-24-en-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
Kanamycin A (sulfate) (0 g) Ophtalmokalixan; O-3-amino-3-deoxy-α-D-glucopyranosyl-(→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(→4)]-2-deoxy-D-streptamine, monosulfate
Kanamycin A (sulfate) (25 g) Ophtalmokalixan; O-3-amino-3-deoxy-α-D-glucopyranosyl-(→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(→4)]-2-deoxy-D-streptamine, monosulfateCID-20756 (0 mg) 5-(3-chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furancarboxamide
CID-20756 (25 mg) 5-(3-chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furancarboxamide
CID-20756 (5 mg) 5-(3-chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furancarboxamide
DBeQ (0 mg) JRF 2|N,N’-Dibenzylquinazoline-2,4-diamine; N2,N4-bis(phenylmethyl)-2,4-quinazolinediamine
DBeQ (25 mg) JRF 2|N,N’-Dibenzylquinazoline-2,4-diamine; N2,N4-bis(phenylmethyl)-2,4-quinazolinediamine
DBeQ (5 mg) JRF 2|N,N’-Dibenzylquinazoline-2,4-diamine; N2,N4-bis(phenylmethyl)-2,4-quinazolinediamine
DBeQ (50 mg) JRF 2|N,N’-Dibenzylquinazoline-2,4-diamine; N2,N4-bis(phenylmethyl)-2,4-quinazolinediamine
Ginsenoside Rb (0 mg) Gypenoside III|NSC 3003; 20-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-2β-hydroxydammar-24-en-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
Ginsenoside Rb (25 mg) Gypenoside III|NSC 3003; 20-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-2β-hydroxydammar-24-en-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
Ginsenoside Rb (5 mg) Gypenoside III|NSC 3003; 20-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-2β-hydroxydammar-24-en-3β-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
Kanamycin A (sulfate) (0 g) Ophtalmokalixan; O-3-amino-3-deoxy-α-D-glucopyranosyl-(→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(→4)]-2-deoxy-D-streptamine, monosulfate
Kanamycin A (sulfate) (25 g) Ophtalmokalixan; O-3-amino-3-deoxy-α-D-glucopyranosyl-(→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(→4)]-2-deoxy-D-streptamine, monosulfate
三羥甲基氨基甲烷鹽酸鹽85-53- | 2-丙烯酰氨基-2-甲基--丙磺酸524-89-8 | PH標(biāo)準(zhǔn)溶液 | 小鼠細(xì)胞分離液 |
大鼠細(xì)胞分離液 | 羥丙基纖維素 | 熬和樹脂 | 732陽離子交換樹脂 |
Amberlite XAD7HP離子交換大孔吸附樹脂37380-43- | 離子交換大孔吸附樹脂 | ||